Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2023 09:30 ET | Source: FLYR Labs

FLYR Labs Appoints John Tzioufas as Chief Revenue Officer

LOS ANGELES, March 23, 2023 (GLOBE NEWSWIRE) -- FLYR Labs, the pioneer of The Commercial Operating System for Travel, today announced the appointment of John Tzioufas as its new Chief Revenue...
March 08, 2023 07:00 ET | Source: ONL Therapeutics

ONL Therapeutics Closes First Tranche of $15 Million Series C Financing to Advance Lead Compound into Phase 2 Clinical Trial

ANN ARBOR, Mich., March 08, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
February 13, 2023 07:00 ET | Source: ONL Therapeutics

ONL Therapeutics to Present at the XXVth Biennial Meeting of the International Society for Eye Research

ANN ARBOR, Mich., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
February 02, 2023 07:00 ET | Source: ONL Therapeutics

ONL Therapeutics to Present at 2023 BIO CEO & Investor Conference

ANN ARBOR, Mich., Feb. 02, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
February 01, 2023 07:00 ET | Source: ONL Therapeutics

ONL Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for ONL1204 Ophthalmic Solution

ANN ARBOR, Mich., Feb. 01, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
January 30, 2023 10:00 ET | Source: Lumotive

Lumotive and Lumentum Introduce Innovative Reference Design to Enable Faster Adoption of Next-Generation 3D LiDAR Solutions

SEATTLE and SAN JOSE, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Lumotive, the developer of Light Control Metasurface (LCM™) beam steering chips enabling the next generation of 3D sensors, and Lumentum...
January 26, 2023 07:00 ET | Source: ONL Therapeutics

ONL Therapeutics to Highlight New Data in Upcoming Scientific Presentations at the 46th Annual Macula Society Meeting and the XXVth Biennial Meeting of the International Society for Eye Research

ANN ARBOR, Mich., Jan. 26, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
January 16, 2023 07:30 ET | Source: Percept

Percept Corporation Names Vision Industry Leader Jim McGrann as President and Chief Operating Officer

LAS VEGAS, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Percept Corporation, a developer of eye tracking, eye control, and perceptual optimization technology for the global vision industry, is pleased to...
October 24, 2022 13:05 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022

PETALUMA, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies, Inc. OTCQB: RTGN to Present at the Emerging Growth Conference. RetinalGeniX Technologies, Inc. (RTGN) is pleased to...
October 20, 2022 08:00 ET | Source: Mindera Health

Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients

San Diego, CA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Interim clinical utility and patient outcomes data regarding Mindera Health’s Mind.Px™ test from the ongoing MATCH study were recently presented at...